Back
Leggett & Platt Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
25
LEG
Leggett & Platt
Last Price:
12.88
Seasonality Move:
-0.09%
Buy
59
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
51.21
Seasonality Move:
-8.66%
Sell
25
Leggett & Platt (LEG)
is a Sell
Is Leggett & Platt a Buy, Sell or Hold?
- The current Leggett & Platt [LEG] share price is $12.84. The Score for LEG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- LEG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $53.88. The Score for CRBP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LEG Stock Price Chart
What is Leggett & Platt's stock price today?
-
The Leggett & Platt share price today is $12.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LEG is experiencing slight selling pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $53.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
LEG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 58.78 | Buy |
| Chaikin Money Flow: | -647884 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.86 - 12.72) | Buy |
| Bollinger Bands (100): | (10.94 - 13.96) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 48.42 | Sell |
| Chaikin Money Flow: | -181169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.35 - 58.73) | Sell |
| Bollinger Bands (100): | (42.58 - 56.82) | Buy |
LEG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.98 | Buy |
| 20-day SMA: | 12.3 | Buy |
| 50-day SMA: | 12.41 | Buy |
| 200-day SMA: | 17.24 | Sell |
| 8-day EMA: | 12.25 | Buy |
| 20-day EMA: | 12.26 | Buy |
| 50-day EMA: | 12.43 | Buy |
| 200-day EMA: | 16.59 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.97 | Buy |
| 20-day SMA: | 56.13 | Sell |
| 50-day SMA: | 55.69 | Sell |
| 200-day SMA: | 36.31 | Buy |
| 8-day EMA: | 54.05 | Sell |
| 20-day EMA: | 54.84 | Sell |
| 50-day EMA: | 53.86 | Buy |
| 200-day EMA: | 39.55 | Buy |
Leggett & Platt Earnings Growth & LEG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.26 per share, and an increase next year of $0.15 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.12 per share, an increase next quarter of $0.03 per share, an increase this year of $7.24 per share, and a decrease next year of $0.09 per share.
Leggett & Platt Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||